Pricing
Login
Home
Charts
Search
Watchlist
Products

Natco Pharma Ltd

NATCOPHARM
₹814.30-0.93%20 Nov 2026
Reports
Pharma Formulations

Natco Pharma Ltd

NATCOPHARM
₹814.30
-0.93%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹15,974Cr
Close
Close Price
₹814.30
Industry
Industry
Pharma Formulations
PE
Price To Earnings
17.74
PS
Price To Sales
5.17
Revenue
Revenue
₹3,089Cr
Rev Gr TTM
Revenue Growth TTM
-29.60%
PAT Gr TTM
PAT Growth TTM
-56.44%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
7591,0681,3631,3714751,2211,3291,363647739735967
Growth YoY
Revenue Growth YoY%
54.019.019.532.9-37.414.3-2.5-0.636.3-39.5-44.7-29.0
Expenses
ExpensesCr
491571558567436673758784489612549709
Operating Profit
Operating ProfitCr
26849780580439548571579159128187258
OPM
OPM%
35.346.559.158.78.244.943.042.524.517.325.426.7
Other Income
Other IncomeCr
37424864176666210058785952
Interest Expense
Interest ExpenseCr
565441031310111318
Depreciation
DepreciationCr
445644464798585246504749
PBT
PBTCr
256478804818164506572614161144186243
Tax
TaxCr
449113514231100929621-896370
PAT
PATCr
213386669677132406480518140233122173
Growth YoY
PAT Growth YoY%
241.440.159.083.3-37.85.1-28.1-23.46.0-42.5-74.6-66.5
NPM
NPM%
28.036.249.149.327.933.336.138.021.731.616.617.9
EPS
EPS₹
11.821.437.037.57.422.526.628.78.414.811.411.2
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
7591,0681,3631,3714751,2211,3291,363647739735967
Growth YoY
Revenue Growth YoY%
54.019.019.532.9-37.414.3-2.5-0.636.3-39.5-44.7-29.0
Expenses
ExpensesCr
491571558567436673758784489612549709
Operating Profit
Operating ProfitCr
26849780580439548571579159128187258
OPM
OPM%
35.346.559.158.78.244.943.042.524.517.325.426.7
Other Income
Other IncomeCr
37424864176666210058785952
Interest Expense
Interest ExpenseCr
565441031310111318
Depreciation
DepreciationCr
445644464798585246504749
PBT
PBTCr
256478804818164506572614161144186243
Tax
TaxCr
449113514231100929621-896370
PAT
PATCr
213386669677132406480518140233122173
Growth YoY
PAT Growth YoY%
241.440.159.083.3-37.85.1-28.1-23.46.0-42.5-74.6-66.5
NPM
NPM%
28.036.249.149.327.933.336.138.021.731.616.617.9
EPS
EPS₹
11.821.437.037.57.422.526.628.78.414.811.411.2

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,0422,0202,1852,0951,9152,0521,9452,7073,9994,4304,0783,089
Growth
Revenue Growth%
26.393.88.2-4.1-8.67.2-5.239.247.710.8-7.9-29.6
Expenses
ExpensesCr
7771,3371,2561,3001,3321,4461,6811,7722,2472,2342,6422,358
Operating Profit
Operating ProfitCr
2666839287955836062649361,7512,1961,437731
OPM
OPM%
25.533.842.538.030.429.513.634.643.849.635.223.7
Other Income
Other IncomeCr
10144013010710499105128355298247
Interest Expense
Interest ExpenseCr
231915192213181519243751
Depreciation
DepreciationCr
51546681100117143164187235207193
PBT
PBTCr
2026248878255695802028621,6742,2911,491734
Tax
TaxCr
481401921821111373214728540811965
PAT
PATCr
1544856956424584421707151,3881,8831,372669
Growth
PAT Growth%
15.7215.743.4-7.6-28.7-3.4-61.6320.894.135.7-27.2-56.4
NPM
NPM%
14.724.031.830.723.921.68.726.434.742.533.621.7
EPS
EPS₹
9.127.638.934.725.124.09.238.976.7104.478.645.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,0422,0202,1852,0951,9152,0521,9452,7073,9994,4304,0783,089
Growth
Revenue Growth%
26.393.88.2-4.1-8.67.2-5.239.247.710.8-7.9-29.6
Expenses
ExpensesCr
7771,3371,2561,3001,3321,4461,6811,7722,2472,2342,6422,358
Operating Profit
Operating ProfitCr
2666839287955836062649361,7512,1961,437731
OPM
OPM%
25.533.842.538.030.429.513.634.643.849.635.223.7
Other Income
Other IncomeCr
10144013010710499105128355298247
Interest Expense
Interest ExpenseCr
231915192213181519243751
Depreciation
DepreciationCr
51546681100117143164187235207193
PBT
PBTCr
2026248878255695802028621,6742,2911,491734
Tax
TaxCr
481401921821111373214728540811965
PAT
PATCr
1544856956424584421707151,3881,8831,372669
Growth
PAT Growth%
15.7215.743.4-7.6-28.7-3.4-61.6320.894.135.7-27.2-56.4
NPM
NPM%
14.724.031.830.723.921.68.726.434.742.533.621.7
EPS
EPS₹
9.127.638.934.725.124.09.238.976.7104.478.645.9
Sales CAGR
1 Year-8%
3 Years15%
5 Years15%
TTM-30%
EBITDA CAGR
1 Year-35%
3 Years15%
5 Years19%
TTM-58%
PAT CAGR
1 Year-27%
3 Years24%
5 Years25%
TTM-56%
Avg. ROCE
1 Year15%
3 Years24%
5 Years19%
TTM7%
CFO / EBITDA
1 Year123%
3 Years87%
5 Years85%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
353537373637373736363636
Reserves
ReservesCr
1,2611,6143,0353,4533,7374,0854,2274,8375,8177,5719,1859,729
Current Liabilities
Current LiabilitiesCr
4936275927296855267106839739441,6811,950
Non Current Liabilities
Non Current LiabilitiesCr
28384783118143135101807517284
Total Liabilities
Total LiabilitiesCr
1,8222,3183,7154,3034,5884,7925,1095,6576,9068,63111,07411,799
Current Assets
Current AssetsCr
8371,0872,1312,3472,3262,3372,4973,0004,0245,2705,0524,235
Non Current Assets
Non Current AssetsCr
9851,2301,5841,9562,2622,4552,6122,6572,8833,3616,0217,564
Total Assets
Total AssetsCr
1,8222,3183,7154,3034,5884,7925,1095,6576,9068,63111,07411,799
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
353537373637373736363636
Reserves
ReservesCr
1,2611,6143,0353,4533,7374,0854,2274,8375,8177,5719,1859,729
Current Liabilities
Current LiabilitiesCr
4936275927296855267106839739441,6811,950
Non Current Liabilities
Non Current LiabilitiesCr
28384783118143135101807517284
Total Liabilities
Total LiabilitiesCr
1,8222,3183,7154,3034,5884,7925,1095,6576,9068,63111,07411,799
Current Assets
Current AssetsCr
8371,0872,1312,3472,3262,3372,4973,0004,0245,2705,0524,235
Non Current Assets
Non Current AssetsCr
9851,2301,5841,9562,2622,4552,6122,6572,8833,3616,0217,564
Total Assets
Total AssetsCr
1,8222,3183,7154,3034,5884,7925,1095,6576,9068,63111,07411,799

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
112346464669417299478491,2121,6971,768
Investing Cash Flow
Investing Cash FlowCr
-176-299-1,116-612-167-103-5-477-1,033-1,415-2,082
Financing Cash Flow
Financing Cash FlowCr
154-48651-51-251-18635-363-247-211298
Net Cash Flow
Net Cash FlowCr
90-1-27-110769-6872-16
Free Cash Flow
Free Cash FlowCr
-4467592308489-1337338741,3911,381
CFO To PAT
CFO To PAT%
73.071.366.7104.191.167.527.4118.787.390.1128.9
CFO To EBITDA
CFO To EBITDA%
42.250.649.984.271.649.317.690.869.277.3123.1
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
112346464669417299478491,2121,6971,768
Investing Cash Flow
Investing Cash FlowCr
-176-299-1,116-612-167-103-5-477-1,033-1,415-2,082
Financing Cash Flow
Financing Cash FlowCr
154-48651-51-251-18635-363-247-211298
Net Cash Flow
Net Cash FlowCr
90-1-27-110769-6872-16
Free Cash Flow
Free Cash FlowCr
-4467592308489-1337338741,3911,381
CFO To PAT
CFO To PAT%
73.071.366.7104.191.167.527.4118.787.390.1128.9
CFO To EBITDA
CFO To EBITDA%
42.250.649.984.271.649.317.690.869.277.3123.1

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
7,17714,76413,91510,5159,21515,04613,82210,29017,04214,28817,46315,974
Price To Earnings
Price To Earnings
45.630.420.016.220.034.181.314.412.37.612.317.7
Price To Sales
Price To Sales
6.97.36.45.04.87.37.13.84.33.24.35.2
Price To Book
Price To Book
5.59.04.53.02.43.63.22.12.91.91.91.4
EV To EBITDA
EV To EBITDA
27.221.915.013.416.324.853.310.69.45.611.621.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
62.863.173.474.970.266.960.068.575.577.674.074.0
OPM
OPM%
25.533.842.538.030.429.513.634.643.849.635.223.7
NPM
NPM%
14.724.031.830.723.921.68.726.434.742.533.621.7
ROCE
ROCE%
16.134.427.821.814.413.54.717.427.229.415.47.3
ROE
ROE%
11.829.422.618.412.110.74.014.723.724.814.96.8
ROA
ROA%
8.420.918.714.910.09.23.312.620.121.812.45.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
7,17714,76413,91510,5159,21515,04613,82210,29017,04214,28817,46315,974
Price To Earnings
Price To Earnings
45.630.420.016.220.034.181.314.412.37.612.317.7
Price To Sales
Price To Sales
6.97.36.45.04.87.37.13.84.33.24.35.2
Price To Book
Price To Book
5.59.04.53.02.43.63.22.12.91.91.91.4
EV To EBITDA
EV To EBITDA
27.221.915.013.416.324.853.310.69.45.611.621.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
62.863.173.474.970.266.960.068.575.577.674.074.0
OPM
OPM%
25.533.842.538.030.429.513.634.643.849.635.223.7
NPM
NPM%
14.724.031.830.723.921.68.726.434.742.533.621.7
ROCE
ROCE%
16.134.427.821.814.413.54.717.427.229.415.47.3
ROE
ROE%
11.829.422.618.412.110.74.014.723.724.814.96.8
ROA
ROA%
8.420.918.714.910.09.23.312.620.121.812.45.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr22,44020,46118,27515,97415,42414,89413,842
Close PriceClose₹822.651,040.951,317.20814.302,029.10935.052,263.20
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE28.4724.2525.6017.7422.3856.2966.86
Price To SalesPS3.812.415.495.176.471.658.88
RevenueRevenueCr5,8958,4773,3303,0892,3839,0121,559
Revenue Growth TTMRev Gr TTM%21.8%19.7%11.1%-29.6%16.8%18.3%20.0%
PAT Growth TTMPAT Gr TTM%39.1%32.9%60.0%-56.4%17.4%-44.7%18.3%
Market CapitalizationMkt CapCr22,44020,46118,27515,97415,42414,89413,842
Close PriceClose₹822.651,040.951,317.20814.302,029.10935.052,263.20
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE28.4724.2525.6017.7422.3856.2966.86
Price To SalesPS3.812.415.495.176.471.658.88
RevenueRevenueCr5,8958,4773,3303,0892,3839,0121,559
Revenue Growth TTMRev Gr TTM%21.8%19.7%11.1%-29.6%16.8%18.3%20.0%
PAT Growth TTMPAT Gr TTM%39.1%32.9%60.0%-56.4%17.4%-44.7%18.3%
Interviews